BioPharma Credit PLC (BPCR) — Cash Flow Quality Index
BioPharma Credit PLC (BPCR) has a Cash Flow Quality Index of 0.46x as of June 2025. Operating cash flow of $33.76 Million is below net income of $72.78 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BioPharma Credit PLC (BPCR) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioPharma Credit PLC Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for BioPharma Credit PLC across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is BioPharma Credit PLC's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BioPharma Credit PLC (2017–2024)
Year-by-year earnings quality comparison for BioPharma Credit PLC. For live market cap and the full company financial profile, see BioPharma Credit PLC stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | $111.91 Million | $122.18 Million | ▼ -19.4% |
| 2023 | 1.14x | $123.18 Million | $108.45 Million | ▲ +12.4% |
| 2022 | 1.01x | $184.28 Million | $182.31 Million | ▼ -11.0% |
| 2021 | 1.14x | $96.44 Million | $84.96 Million | ▲ +74.2% |
| 2020 | 0.65x | $58.07 Million | $89.14 Million | ▼ -39.4% |
| 2019 | 1.08x | $131.52 Million | $122.33 Million | ▲ +12.3% |
| 2018 | 0.96x | $67.14 Million | $70.15 Million | ▲ +12.7% |
| 2017 | 0.85x | $23.07 Million | $27.16 Million | — |